🇺🇸 FDA
Pipeline program

LAD328, SODIUM CHLORIDE

M-00401-10

Phase 2 small_molecule active

Quick answer

LAD328, SODIUM CHLORIDE for moderate-to-severe hidradenitis suppurativa is a Phase 2 program (small_molecule) at Almirall with 1 ClinicalTrials.gov record(s).

Program details

Company
Almirall
Indication
moderate-to-severe hidradenitis suppurativa
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials